Clinical reference Biomarker Directory
Back to directory

AMH

Established

AMH is a reproductive hormone used to assess ovarian reserve and diagnose/monitor granulosa cell tumors.

Also known as Anti-Mullerian hormone Mullerian inhibiting substance
In plain language

AMH is a hormone that reflects how many eggs a woman has left, helping guide fertility treatment planning. It is also a very accurate marker for a rare ovarian tumor called granulosa cell tumor, and doctors use it after surgery to check the tumor hasn't come back.

Biomarker & context

Anti-Müllerian hormone (AMH) is produced by granulosa cells of small ovarian follicles and reflects the size of the remaining egg supply (ovarian reserve). It is stable across the menstrual cycle, making it convenient to test on any day.

What it indicates

AMH is the preferred first-line marker of ovarian reserve, useful in fertility planning and IVF protocol individualization, and is also a strong biomarker for granulosa cell tumor of the ovary, a rare malignancy where levels should become undetectable after complete tumor resection.

Diagnosis & clinical testing

Measured via blood immunoassay; meta-analysis shows AMH has approximately 89% sensitivity and 93% specificity for diagnosing granulosa cell tumors. For fertility purposes, AMH outperforms day-3 FSH and is comparable to antral follicle count on ultrasound.

Guiding treatment

In granulosa cell tumor patients, serial AMH after surgery is used to monitor for recurrence, since levels should normalize to undetectable if resection was complete; rising AMH post-treatment suggests recurrent or residual disease.

Clinical significance

High diagnostic accuracy for granulosa cell tumor; preferred marker for ovarian reserve assessment.

References
  1. Chen, S., Yang, B., & Fan, J. (2020). Diagnostic value of Anti-Mullerian hormone in ovarian granulosa cell tumor: A meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology.